Please check your internet connection and try again.
## Pantoprazole
### Overview
Pantoprazole is a proton pump inhibitor (PPI) that suppresses gastric acid secretion.
### Primary Indications
* Healing of erosive esophagitis associated with GERD.
* Maintenance of healing of erosive esophagitis.
* Treatment of pathological hypersecretory conditions, such as Zollinger-Ellison syndrome.
### Adult Dosing
* **Erosive esophagitis:** 40 mg orally once daily for up to 8 weeks. A subsequent 8-week course may be considered for patients who have not healed.
* **Maintenance of healing:** 40 mg orally once daily.
* **Pathological hypersecretory conditions:** Starting dose is 40 mg orally twice daily, with titration based on clinical response. Doses up to 240 mg daily have been administered intravenously.
### Pediatric Dosing
* **Erosive esophagitis (age 5-15 years):** 40 mg orally once daily for up to 4 weeks.
* **Erosive esophagitis (age 16-17 years):** Same as adult dosing.
* **Note:** Dosing for younger pediatric patients or for indications beyond erosive esophagitis may depend on local protocols and specialist guidance.
### Dose Adjustments
* **Hepatic impairment:** Maximum dose of 40 mg orally once daily.
* **Renal impairment:** No dose adjustment required.
### Contraindications
* Known hypersensitivity to pantoprazole or any of its components.
### Adverse Effects
Common adverse effects include headache, diarrhea, nausea, abdominal pain, and dizziness. Long-term use of PPIs may be associated with an increased risk of fractures, C. difficile infection, and vitamin B12 deficiency.
### Key Drug Interactions
* **Clopidogrel:** Pantoprazole may decrease the efficacy of clopidogrel. Consider alternative PPIs or monitor for thrombotic events.
* **Methotrexate:** Concomitant use may increase methotrexate levels. Consider dose reduction or temporary discontinuation of pantoprazole.
* **Drugs dependent on gastric pH for absorption:** Antiretrovirals (e.g., rilpivirine, atazanavir), antifungals (e.g., ketoconazole, itraconazole), and iron salts may have decreased absorption.
### Monitoring
* Monitor for signs and symptoms of hypomagnesemia (e.g., muscle spasms, seizures, tremors).
* Monitor for signs of fracture, C. difficile infection, and vitamin B12 deficiency with long-term use.
### Clinical Pearls
* Administer pantoprazole delayed-release tablets or capsules 30 minutes before a meal.
* IV pantoprazole is available for patients unable to take oral medication.
* The risk of fracture, C. difficile, and B12 deficiency increases with duration of use; use the lowest effective dose for the shortest duration necessary.
**Educational Disclaimer:** This information is intended for clinical pharmacists and healthcare professionals. Always consult the most current prescribing information and institutional guidelines for definitive patient care decisions.
